Breaks Categories: Stock Spotlights

MondayMay 01, 2017 12:33 pm

NetworkNewsBreaks – Amyris, Inc. (NASDAQ: AMRS) Advances Development of Healthy Sweetener; Industrial Production Set For 2018

Amyris (NASDAQ: AMRS) shares surged over 9% this morning after the company said it has made noteworthy progress in the development of its healthy sweetener product technology and that it expects industrial production to occur in 2018. Amyris is developing a low calorie, sustainably sourced No Compromise® sweetener intended to be sold at a lower cost than sugar. “Our efforts to give the consumer sustainably sourced, best performing products without dangerous ingredients is really starting to payoff. We believe we have the leading market position for sustainable, healthy sweeteners and we are very excited about helping the world transition away…

Continue Reading

MondayMay 01, 2017 10:47 am

NetworkNewsBreaks – Aeterna Zentaris Inc. (NASDAQ: AEZS) Shares Sink on Disappointing Zoptrex™ Trial Results; Company Re-routes Focus to Macrilen™

Shares of Aeterna Zentaris Inc. (NASDAQ: AEZS) plunged 58% this morning after the company said its phase 3 clinical trial of Zoptrex™ in women with locally advanced, recurrent or metastatic endometrial cancer failed to show a statistically significant increase in the average period of overall survival of patients treated with Zoptrex as compared to patients treated with doxorubicin. Based on the results, Aeterna CEO David Dodd said the company would not conduct clinical trials of Zoptrex for other indications and will turn its focus to filing a new drug application (NDA) for Macrilen™ for eventual commercial launch. To view the full…

Continue Reading

FridayApr 28, 2017 12:06 pm

NetworkNewsBreaks – UniPixel, Inc. (NASDAQ: UNXL) Increases Manufacturing Capability; Shares Climb

Shares of UniPixel (NASDAQ: UNXL) are up 15% mid-morning after the company said that it has taken delivery of a new custom built, high-speed coating system for the application of its Diamond Guard™ glass replacement resin compound. The system is scheduled for installation in May 2017 and is expected to commence production in June 2017 to provide enhanced protection coating for the company’s XTouch™ sensors. "The addition of this advanced technology equipment, in addition to yield improvement, expands our Diamond Guard application capabilities at just the right time. We are making measurable progress in applying our Diamond Guard glass replacement…

Continue Reading

ThursdayApr 27, 2017 2:12 pm

NetworkNewsBreaks – ProBility Media Corp. (PBYA) Aims to Occupy Leading Position in Construction Industry Training

ProBility Media (OTCQB: PBYA) recently acquired One Exam Prep LLC, gaining ground on its goal to become a leader in continuing education in the construction industry. “The company also expects its technology-driven construction training and education services to eventually be offered internationally. For now, its services are reinforcing continuous workplace learning and allowing workers all over the country to begin and advance their careers. ProBility’s unprecedented growth is showing in other ways, too. Recently, OTC Markets uplisted the company to the QB Tier, which requires annual certification and consistent reporting with the Securities and Exchange Commission. Its string of successful…

Continue Reading

ThursdayApr 27, 2017 12:12 pm

NetworkNewsBreaks – SinglePoint, Inc.’s (SING) Unique Strategy Aims to Remove Risk While Expanding Portfolio

SinglePoint (OTC: SING) continues to pursue strategic opportunities to widen its foothold in the cannabis industry while hedging itself against potential risks regarding the legality of marijuana. “Focused on innovation, SinglePoint is expanding its portfolio in the cannabis markets with the strategic acquisition of companies that profit from the cannabis industry but don’t touch the plant itself. There’s little doubt that the marijuana market in the United States will continue to flourish and is poised for explosive upside growth. SinglePoint’s strategy positions the company to maximize profit from the marijuana markets yet virtually eliminate any downside risk exposure. The company’s…

Continue Reading

ThursdayApr 27, 2017 12:12 pm

NetworkNewsBreaks – Moxian (NASDAQ: MOXC) Generates E-Commerce Through Social Media Marketing

An April 2016 report by McKinsey & Company, Consumer China 2016 Survey (http://nnw.fm/QHb20), suggests that social media is gaining importance for companies like Moxian (NASDAQ: MOXC). “Moxian, Inc. is committed to growth in China’s online-to-offline (O2O) retail market, which is predicted by the Chinese to reach $48 billion in 1H17. Social media, an important part of Moxian’s marketing strategy, is playing a growing role in generating e-commerce apparel and dining revenues, research shows. A report by McKinsey & Company finds that the online market is changing retail buying patterns within China. Moxian is a high technology company which is transitioning…

Continue Reading

WednesdayApr 26, 2017 12:03 pm

NetworkNewsBreaks – Lightwave Logic, Inc. (LWLG) Achieves Bandwidth Suitable for 25Gbps in Modulator Prototype

Shares of Lightwave Logic (OTCQB: LWLG) are up 5% in mid-day trade following the company’s news that it has achieved bandwidth suitable for 25Gbps data rates in an all-organic polymer ridge waveguide intensity modulator prototype, representing a significant improvement over its initial 10Gbps device modulator. The Mach-Zehnder design allows Lightwave to address 100Gbps using its polymer photonics integrated circuit technology platform. "We expect that the 25Gbps device will generate significant industry attention as we squarely address powerful, cost-effective miniaturized solutions for both today's 100Gbps, and future 400Gbps higher performance markets," Lightwave CEO Tom Zelibor stated in the news release. To…

Continue Reading

TuesdayApr 25, 2017 4:04 pm

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Issues Update on WeedTV.com, Plans to Launch Beta

In a recent letter to shareholders, Player's Network (OTCQB: PNTV) issued an update on its WeedTV.com platform. The platform has been internally tested and the company said it expects it to have a beta launch in the near future. WeedTV.com will enable any business in the medicinal marijuana industry to create a personalized media network online. In the letter, the company explains that revenue will be generated through licensing of the software that creates and controls each of these personalized media networks. To date, the company has received an estimated $450,000 in product sponsorships from companies who have signed with…

Continue Reading

TuesdayApr 25, 2017 1:01 pm

NetworkNewsBreaks – Galectin Therapeutics, Inc. (NASDAQ: GALT) Receives Decision to Grant From Japanese Patent Office for GR-MD-02 Composition of Matter Patent

Galectin Therapeutics (NASDAQ: GALT) this morning said it has received a decision from the Japanese Patent Office to grant its patent application for "Composition of Novel Carbohydrate Drug for Treatment of Human Diseases." Upon issuance, the patent will expand coverage of the company's lead compound, GR-MD-02, to Japan through 2032. "The allowance of these claims in Japan further strengthens the protection of the intellectual property behind our proprietary compound, GR-MD-02. This is especially important in Japan, which was recently declared the second most attractive drug market in the world," Galectin CEO and chief medical officer Peter G. Traber, M.D. stated…

Continue Reading

TuesdayApr 25, 2017 11:45 am

NetworkNewsBreaks – Intellipharmaceutics International, Inc. (NASDAQ: IPCI) Leveraging Hypermatrix™ Technology to Address Key Pharmaceutical Markets

Intellipharmaceutics International, Inc. (NASDAQ: IPCI) is engaged in the research, development and commercialization of controlled-release and targeted pharmaceutical products. Leveraging its proprietary Hypermatrix™ technology, the company is focused on addressing two key niche markets, including difficult-to-produce controlled-release generic drugs (ANDA regulatory pathway) and improved current therapies through controlled-release (NDA regulatory pathway). Intellipharmaceutics' lead product is a generic of Focalin XR®, a mild central nervous system stimulant used to treat attention deficit hyperactivity disorder. This product is currently marketed in a variety of strengths by the company’s U.S. marketing partner, Par Pharmaceutical, Inc. Intellipharmaceutics’ development pipeline also includes its Rexista™ product…

Continue Reading